靶向VEGF的shRNA纳米传输系统在小鼠肝癌模型中的应用的中期报告.docxVIP

靶向VEGF的shRNA纳米传输系统在小鼠肝癌模型中的应用的中期报告 摘要： 本研究使用一种基于纳米颗粒的传输系统，将针对血管内皮生长因子（VEGF）的短发夹RNA（shRNA）导入小鼠肝癌细胞中。通过体内和体外实验，我们评估了这种纳米传输系统对肝癌细胞和小鼠模型的影响。实验结果表明，该纳米传输系统能够有效地传递shRNA，并在肝癌细胞中显著抑制VEGF的表达。此外，我们还观察到，这种纳米传输系统能够明显降低肝癌细胞在小鼠体内的生长速度，并减少血管新生和坏死区域的数量。 结论： 我们的研究为靶向VEGF的shRNA纳米传输系统在肝癌治疗中的应用提供了初步的证据。这种纳米传输系统可以在不影响健康细胞的情况下，针对肝癌细胞实现精准治疗。未来的研究可以在进一步优化纳米传输系统的稳定性和效率的基础上，探索其在临床治疗中的应用前景。 Abstract: This study used a nanoparticle-based delivery system to deliver short hairpin RNA (shRNA) targeting vascular endothelial growth factor (VEGF) into mouse liver cancer cells. The impact of this nanoparticle delivery system on liver cancer cells and mouse models was evaluated through in vivo and in vitro experiments. The results of this study demonstrated that this nanoparticle delivery system could effectively deliver shRNA and significantly suppress VEGF expression in liver cancer cells. Moreover, this nanoparticle delivery system significantly reduced the growth rate of liver cancer cells in the mouse model and decreased the number of areas of vascular neovascularization and necrosis. Conclusion: Our study provides initial evidence for the application of a nanoparticle-based delivery system of shRNA targeting VEGF in liver cancer treatment. This nanoparticle delivery system allows for precise treatment of liver cancer cells without affecting healthy cells. Future research may explore the potential applications of this delivery system in clinical treatments, building upon stabilizing its efficiency and efficacy in vivo.